Skip to main content

4 Result(s)

within Xuguang Mi Remove this filter

and

  1. No Access

    Article

    Advances in the treatment of malignant ascites in China

    Malignant ascites (MA) often occurs in recurrent abdominal malignant tumors, and the large amount of ascites associated with cancerous peritonitis not only leads to severe abdominal distension and breathing di...

    Junzi Zhang, Zhaoxue Qi, Wenjie Ou, Xuguang Mi, Yanqiu Fang… in Supportive Care in Cancer (2024)

  2. Article

    Open Access

    Elevation of effective p53 expression sensitizes wild-type p53 breast cancer cells to CDK7 inhibitor THZ1

    The cyclin-dependent kinase 7 (CDK7) inhibitor THZ1 represses multiple cancer cells. However, its tumor-repressive efficiency in wild-type p53 breast cancer cells remains controversial.

    Yueyuan Wang, Zhihao Zhang, Xuguang Mi, Mingxi Li… in Cell Communication and Signaling (2022)

    Download PDF (9948 KB) View Article

  3. Article

    Open Access

    MiR-199a/b-3p inhibits colorectal cancer cell proliferation, migration and invasion through targeting PAK4 and BCAR3

    Colorectal cancer (CRC) is one of the leading causes of cancer-related death worldwide. P21 activated kinase 4 (PAK4) and Breast cancer anti-estrogen resistance 3 (BCAR3) have been reported to be involved in nume...

    Junjie Hou, Xuguang Mi, Ning Liu, **aonan Li… in European Journal of Medical Research (2022)

    Download PDF (2882 KB) View Article

  4. No Access

    Article

    HBx interacted with Smad4 to deprive activin a growth inhibition function in hepatocyte HL7702 on CRM1 manner

    Hepatitis B virus (HBV) is implicated in the pathogenesis of hepatocellular carcinoma, which has been found to be associated with TGF-beta signaling. Activin A is a TGF-β family cytokine that exhibits cell pro...

    Ying Shi, Haipeng Zhang, Zhu Han, Xuguang Mi, Wenyan Zhang, Mingyu Lv in Tumor Biology (2016)